CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genzyme,
a Sanofi company (EURONEXT: SAN and NYSE: SNY), announced today that
scientists have named the company one of the most highly regarded
employers in the biopharmaceutical industry. In a survey commissioned by Science
and the American Association for the Advancement of Science, Genzyme
ranked among 20 companies in the industry with the best reputations as
employers. Genzyme was recognized in particular for valuing and
respecting its scientists, for its social responsibility, and for doing
important, quality research.
“We continue to foster an environment of interconnectivity within our
R&D organization, in which all employees have a shared focus on
discovering and developing medicines to make a difference in patients’
lives”
This is the 10th consecutive year that Genzyme has earned this
distinction.
“We continue to foster an environment of interconnectivity within our
R&D organization, in which all employees have a shared focus on
discovering and developing medicines to make a difference in patients’
lives,” said Rich Gregory, Senior Vice President and Head of the
Sanofi-Genzyme R&D Center.
More than 4,000 Science readers globally participated in the
survey. Fifty-six percent of respondents work in biotechnology and 35
percent for a pharmaceutical company. Twenty-three percent of
respondents reported working in basic research, 30 percent in applied
research, and 30 percent in development. Seventy-eight percent of
respondents were based in North America, 14 percent in Europe, and 5
percent in the Asia/Pacific Rim.
About Genzyme, a Sanofi Company
Genzyme has pioneered the development and delivery of transformative
therapies for patients affected by rare and debilitating diseases for
over 30 years. We accomplish our goals through world-class research and
with the compassion and commitment of our employees. With a focus on
rare diseases and multiple sclerosis, we are dedicated to making a
positive impact on the lives of the patients and families we serve. That
goal guides and inspires us every day. Genzyme’s portfolio of
transformative therapies, which are marketed in countries around the
world, represents groundbreaking and life-saving advances in medicine.
As a Sanofi company, Genzyme benefits from the reach and resources of
one of the world’s largest pharmaceutical companies, with a shared
commitment to improving the lives of patients. Learn more at www.genzyme.com.
About Sanofi
Sanofi, a global and diversified healthcare leader, discovers, develops
and distributes therapeutic solutions focused on patients’ needs. Sanofi
has core strengths in the field of healthcare with seven growth
platforms: diabetes solutions, human vaccines, innovative drugs,
consumer healthcare, emerging markets, animal health and the new
Genzyme. Sanofi is listed in Paris (EURONEXT: SAN) and in New York
(NYSE: SNY).